• Health & Medicine

Immunotherapy for triple negative breast cancer approved for NHS in England 

Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer. Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer.

26 May 2020

• Science & Technology
• Health & Medicine

News digest – 15-minute prostate test, COVID-19 AI database, CAR T cell therapy and cancer ancestry links

An AI-powered database is collating global COVID-19 research to accelerate the search for treatments. An AI-powered database is collating global COVID-19 research to accelerate the search for treatments.

16 May 2020

• Health & Medicine

Coronavirus and cancer – May updates

We’re pulling together the latest government and NHS health updates concerning coronavirus (COVID-19) and cancer from May. We’re pulling together the latest government and NHS health updates concerning coronavirus (COVID-19) and cancer from May.

4 May 2020

• Health & Medicine

News digest – cancer blood test, prostate cancer treatment, cancer risk and breast cancer radiotherapy

A targeted cancer drug, already used to treat some breast and ovarian cancers, has also been found to be effective for some men with advanced prostate cancer. A targeted cancer drug, already used to treat some breast and ovarian cancers, has also been found to be effective for some men with advanced prostate cancer.

2 May 2020

• Health & Medicine

Breast and ovarian cancer drug effective in advanced prostate cancer

A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer. A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer.

1 May 2020

• Science & Technology
• Health & Medicine

News digest – targeted treatment approval, prostate cancer deaths and antlers?

A 'breakthrough' targeted cancer drug has been approved for NHS use in England. A 'breakthrough' targeted cancer drug has been approved for NHS use in England.

25 April 2020

• Health & Medicine

Our nurse helpline during coronavirus: ‘We’re here to help people understand what’s happening’

Since the COVID-19 virus began to disrupt everyone’s lives, the Cancer Research UK helpline hasn’t stopped ringing. Since the COVID-19 virus began to disrupt everyone’s lives, the Cancer Research UK helpline hasn’t stopped ringing.

23 April 2020

• Health & Medicine

New breed of personalised cancer medicine approved in England. What does it mean for patients?

A new breed of targeted cancer drug has been approved for NHS use in England. But drugs like larotrectinib also pose unique and complex challenges for the NHS, which have been exacerbated by the COVID-19 pandemic. A new breed of targeted cancer drug has been approved for NHS use in England. But drugs like larotrectinib also pose unique and complex challenges for the NHS, which have been exacerbated by the COVID-19 pandemic.

21 April 2020

• Health & Medicine
• Policy & Insight

How coronavirus is impacting cancer services in the UK

Cancer services have been severely disrupted across the UK, from screening to treatment and care. Cancer services have been severely disrupted across the UK, from screening to treatment and care.

21 April 2020

• Science & Technology
• Health & Medicine

News digest – ‘stealth’ nanoparticles, children’s brain tumours, lung cancer immunotherapy and aspirin

Scientists have developed nanoparticles that can slip through the blood-brain barrier in mice. Scientists have developed nanoparticles that can slip through the blood-brain barrier in mice.

18 April 2020